Relmada Therapeutics Inc. (RLMD)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
9 |
$663,373 |
Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
31 Jan 2024 |
TRAVERSA SERGIO |
Chief Executive Officer |
31 Jan 2024 |
27,460 |
4.00 |
109,752 |
31 Jan 2024 |
TRAVERSA SERGIO |
Chief Executive Officer |
30 Jan 2024 |
40,999 |
3.90 |
159,949 |
31 Jan 2024 |
TRAVERSA SERGIO |
Chief Executive Officer |
29 Jan 2024 |
31,541 |
3.71 |
117,036 |
31 Jan 2024 |
SHENOUDA MAGED |
Chief Financial Officer |
31 Jan 2024 |
6,875 |
4.06 |
27,943 |
31 Jan 2024 |
SHENOUDA MAGED |
Chief Financial Officer |
30 Jan 2024 |
15,000 |
3.89 |
58,323 |
31 Jan 2024 |
SHENOUDA MAGED |
Chief Financial Officer |
29 Jan 2024 |
10,800 |
3.65 |
39,450 |
31 Jan 2024 |
ENCE CHUCK |
CA and CO |
31 Jan 2024 |
13,670 |
4.05 |
55,429 |
31 Jan 2024 |
ENCE CHUCK |
CA and CO |
30 Jan 2024 |
14,500 |
3.87 |
56,053 |
31 Jan 2024 |
ENCE CHUCK |
CA and CO |
29 Jan 2024 |
10,800 |
3.65 |
39,438 |
24 May 2023 |
O'GORMAN CEDRIC |
Chief Medical Officer |
23 May 2023 |
10,000 |
3.18 |
31,800 |
12 Dec 2022 |
TRAVERSA SERGIO |
Chief Executive Officer |
08 Dec 2022 |
55,250 |
2.10 |
115,804 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock